Read More

BioVie Announces That Blinded Data Presented Suggest That NE3107 Is Biologically Active And May Have Impact On Cognitive, Biomarker, And Imaging Endpoints Among Mild To Moderate Alzheimer’s Disease Patients At CTAD

Statistically significant population changes from baseline were observed for all primary and secondary cognitive and functional assessments measured: ADAS-Cog12, ADCS-CGIC, MMSE, CDR, CDR-SB, ADCOMS, and

BIVI